Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, shared clinical validation data for its OncodetectTM MRD test at the 2025 American Society of Clinical Oncology ...

His industry impacting achievements include an instrumental role in establishing polymerase chain reaction (PCR) as a routine ...

Results from the study have been accepted as a poster presentation at the ASCO Gastrointestinal Cancers Symposium ... that can be radiolabeled with either 203 Pb for patient selection and dosimetry ...

These updates include significant inroads in expanding market access, product innovation, commercial growth, advancements in research, as well as key partnerships and awards. This press release ...

Reply to: Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm–Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis ASCO Guidelines ...

If you click on links we provide, we may receive compensation. It’s the little things that make life better Caraway; Kizik; Nordstrom; Amazon Out with the old and in with the new! If you haven ...

A home encounter with Southampton earns Crystal Palace pair Daniel Munoz (£4.7m) and Ismaila Sarr (£5.8m) a place in the best XI for Gameweek 19 of Fantasy Premier League. Attacking wing-back Munoz ...

If there’s one thing HuffPost’s shopping editors can claim to be experts on, it’s naming the products that are legitimately the best. Our round-the-clock tracking of sales and the endless hours spent ...

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal ...

So can you elaborate on the patient selection there for the study ... Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, ...

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 ...